Clinical Trial Update: Study Evaluating the Safety and Efficacy of Astarabine in Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia [Phase 1, Phase 2]

View source ↗

Summary

A completed phase 1/2 trial evaluating safety and efficacy of Astarabine in acute myeloid leukemia and acute lymphoblastic leukemia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia
• Acute Myeloid Leukemia

Drugs mentioned

• Astarabine (Astarabine)

Snippet

Sponsor: BioSight Ltd. | Conditions: Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia | Phase 1, Phase 2 | Status: COMPLETED